SHL Telemedicine Ltd. (SHLT)
NASDAQ: SHLT
· Real-Time Price · USD
2.05
0.00 (0.00%)
At close: Apr 02, 2025, 10:51 AM
SHL Telemedicine Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.84M | -9.03M | -8.14M | -5.82M | -3.45M | -1.23M | -113.55K | -1.93M | -3.79M | -8.96M | -14.11M | -11.98M | -9.97M | -4.76M |
Depreciation & Amortization | 6.51M | 8.13M | 8.03M | 9.64M | 9.88M | 9.8M | 9.75M | 7M | 7M | 4.72M | 4.14M | 5.78M | 5.5M | 6.75M |
Stock-Based Compensation | 787K | 1.02M | 1.25M | 1.41M | 1.56M | 1.66M | 1.76M | 1.76M | 1.77M | 1.53M | 1.29M | 939K | 587K | 334.5K |
Other Working Capital | 650.06K | 862.8K | 982.8K | 947.19K | 390.69K | 412.44K | 609.94K | -626.95K | -1.34M | -1.52M | -1.97M | -1.53M | -1.22M | -1.6M |
Other Non-Cash Items | 654K | 7.77M | 6.48M | 12.09M | 9.24M | 7.82M | 8.83M | 5.65M | 9.56M | 8.45M | 13.32M | 15.21M | 13.41M | 13.09M |
Deferred Income Tax | 410.54K | 410.54K | 410.54K | 339.15K | 339.15K | 339.15K | 339.15K | n/a | n/a | n/a | n/a | 137.11K | 137.11K | 137.11K |
Change in Working Capital | 2.34M | -108.58K | -1.31M | -4.03M | -5.73M | -3.54M | -3.22M | -2.93M | -3.64M | -4.36M | -4.45M | -2.8M | -1.47M | -839.53K |
Operating Cash Flow | 1.45M | -1.64M | -3.11M | -6.06M | -7.86M | -2.62M | -109.1K | 2.38M | 3.7M | 1.39M | 185K | 2.48M | 3.4M | 5.73M |
Capital Expenditures | -1.58M | -3.89M | -3.75M | -7.08M | -7.04M | -7.47M | -7.7M | -4.24M | -4.16M | -1.06M | -625K | -1.59M | -1.66M | -2.16M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -13.08M | -26.17M | -26.74M | -27.32M | -14.24M | -1.16M | -578.5K |
Purchase of Investments | -11.22M | -12.18M | -12.18M | -8.15M | -8.15M | -11.23M | -11.23M | -4.04M | -4.04M | n/a | n/a | -2.81M | -2.81M | -6.77M |
Sales Maturities Of Investments | 7.3M | 8.31M | 8.31M | 2.31M | 2.31M | 11.7M | 11.7M | 10.41M | 10.41M | n/a | n/a | 767.4K | 767.4K | 849.86K |
Other Investing Acitivies | 11.88M | -1.8M | -8.89M | -7.61M | -11.09M | -7.51M | -2.39M | -3.17M | 816.1K | -4.91M | -13.03M | -13.81M | -14.6M | -10.69M |
Investing Cash Flow | 8.23M | -5.63M | -12.58M | -20.53M | -23.97M | -14.52M | -9.61M | -14.13M | -23.14M | -32.72M | -40.97M | -30.39M | -18.15M | -15.97M |
Debt Repayment | n/a | n/a | n/a | -1.09M | -1.09M | -1.66M | -1.66M | -563.67K | -563.67K | n/a | n/a | n/a | n/a | 2.15M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -6.76M | -9.29M | 177.46K | 3.83M | 4.91M | 7.64M | -1.41M | 6.36M | 15.21M | 33.25M | 51.08M | 42.21M | 33.34M | 14.89M |
Financial Cash Flow | -5.27M | 12.29M | 21.76M | 22.49M | 23.56M | 5.64M | -3.41M | 5.79M | 14.65M | 33.25M | 51.08M | 41.85M | 32.98M | 17.4M |
Net Cash Flow | 682.64K | 2.44M | 3.31M | -4.88M | -8.97M | -2.65M | -4.84M | 2.72M | 4.31M | 1.76M | 10.7M | 14.19M | 18.12M | 7.35M |
Free Cash Flow | -127K | -5.53M | -6.86M | -13.14M | -14.9M | -10.09M | -7.81M | -1.86M | -453.57K | 323K | -440K | 888.42K | 1.74M | 3.57M |